Liberty Wealth Management LLC Takes Position in Danaher Corporation (NYSE:DHR)

Key Points

• Liberty Wealth Management LLC acquired a new position in Danaher Corporation, purchasing 17,046 shares valued at approximately $3.49 million during the first quarter.
• In recent financial results, Danaher reported $1.80 EPS, surpassing expectations, with revenue of $5.94 billion and a net margin of 14.21%.
• Danaher declared a quarterly dividend of $0.32 per share, indicating a 0.6% yield and a payout ratio of 27.23%.

Liberty Wealth Management LLC bought a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 17,046 shares of the conglomerate's stock, valued at approximately $3,494,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Fortis Capital Advisors LLC grew its stake in Danaher by 1.3% during the 4th quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate's stock valued at $914,000 after acquiring an additional 50 shares in the last quarter. Fayez Sarofim & Co grew its stake in Danaher by 0.6% during the 4th quarter. Fayez Sarofim & Co now owns 8,287 shares of the conglomerate's stock valued at $1,902,000 after acquiring an additional 50 shares in the last quarter. Coastal Bridge Advisors LLC grew its stake in Danaher by 4.8% during the 4th quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate's stock valued at $252,000 after acquiring an additional 50 shares in the last quarter. Perennial Investment Advisors LLC grew its stake in Danaher by 2.2% during the 4th quarter. Perennial Investment Advisors LLC now owns 2,343 shares of the conglomerate's stock valued at $538,000 after acquiring an additional 51 shares in the last quarter. Finally, MGO One Seven LLC grew its stake in Danaher by 1.3% during the 4th quarter. MGO One Seven LLC now owns 4,285 shares of the conglomerate's stock valued at $984,000 after acquiring an additional 53 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

Several analysts have recently weighed in on DHR shares. Wolfe Research dropped their price target on shares of Danaher from $275.00 to $220.00 and set an "outperform" rating for the company in a research note on Monday, April 7th. Bank of America lowered their price objective on shares of Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. UBS Group lowered their price objective on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research report on Wednesday, July 23rd. Finally, The Goldman Sachs Group lowered their price objective on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research report on Wednesday, April 23rd. Three research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $247.61.

Danaher Stock Up 0.9%

NYSE DHR traded up $1.69 during trading hours on Tuesday, reaching $199.15. 4,001,120 shares of the company's stock were exchanged, compared to its average volume of 4,702,217. The company has a market capitalization of $142.60 billion, a price-to-earnings ratio of 42.37, a price-to-earnings-growth ratio of 2.74 and a beta of 0.73. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90. The company's 50-day moving average is $197.75 and its two-hundred day moving average is $201.87. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter last year, the firm posted $1.72 EPS. The company's quarterly revenue was up 3.4% on a year-over-year basis. On average, analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Insider Transactions at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman owned 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 11.20% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.